Sign up to gain complete access to Medznat
Please verify that you are a Healthcare Professional. Register for complete access to all the content!
Russia’s N protein-based vaccine emerges as strong contender in g...
N protein-based COVID-19 vaccine shows 85.2% efficacy and a strong safety profile, offering a crucial alternative for patients struggling with tr...
Updated non-mRNA COVID vaccine receives FDA approval for enhanced...
The updated non-mRNA COVID-19 vaccine offers targeted protection against Omicron variants for individuals 12+ with enhanced safety and efficacy.
FDA OKs flu shot with the advantage of self-administration like n...
Approval of self-administered flu vaccine paves the way for greater accessibility and flexibility in seasonal flu prevention, offering families a...
Exclusive automated insulin dosing device is now FDA-approved for...
Automated insulin dosing now extends to type 2 diabetes, streamlining daily management and enhancing glycemic control.
Dr. Reddy’s secures Guinness Record with massive mosaic promoting...
Colossal mosaic for 'Glycemic Happiness' reflects a commitment to a holistic approach in diabetes management that values psychological we...
One-of-a-kind non-injection nasal spray is now FDA-sanctioned for...
Epinephrine nasal spray for anaphylaxis offers a needle-free treatment option, reducing delays and overcoming injection fear.
First gene therapy for metastatic synovial sarcoma earns FDA's OK...
Afamitresgene autoleucel intravenous infusion represents a pivotal advance in treating metastatic malignant synovioma, which is crucial for patie...
Takeda and Dr. Reddy’s join forces to launch Vonoprazan in India
Dr. Reddy’s has partnered with Takeda to launch Vonoprazan (VONO™), a novel acid blocker enhancing its GI treatment offerings in Indi...
FDA clears path for Aflibercept Biosimilars in macular degenerati...
Aflibercept Biosimilars intravitreal solutions are now FDA-approved as interchangeable biosimilars.
FDA gives green light to Pivmecillinam for UTI
Pivmecillinam, an extended-spectrum penicillin antibiotic has been approved for women aged 18 and older with uncomplicated urinary tract infectio...
Another high-concentration Adalimumab Biosimilar approved by the...
High-concentration, citrate-free type of adalimumab-adbm that halves injection volume is now approved for chronic inflammatory dis...
FDA approves antibiotic with triple treatment potential!
Ceftobiprole medocaril sodium injection is effective for 3 acute bacterial infections.
This website uses cookies to help us give you the best experience when you visit.
By using this website you consent to our use of cookies. For more information please review our cookie policy.
